Zepbound® (tirzepatide)

Our review

Zepbound® (tirzepatide) is a once-weekly prescription treatment for eligible adults with obesity, or overweight with a related condition. Its dual GIP and GLP-1 activity, clinical-trial outcomes, dosing schedule, contraindications, and side-effect profile should all be considered with a licensed prescriber. This review is limited to the branded product and its labeled indications.

How it works

Tirzepatide is a dual GIP and GLP-1 receptor agonist, which is the technical way of saying it copies two of your gut's appetite hormones instead of one. The GLP-1 half quiets hunger and slows digestion the way every drug in this class does. The added GIP activity seems to amplify the effect, and while researchers still argue about exactly why two targets beat one, the results have been consistent enough that it isn't really in dispute anymore.

What the clinical trials show

SURMOUNT-1 evaluated an investigational tirzepatide drug product, and the resulting evidence subsequently supported FDA approval of Zepbound®. Adults receiving the highest studied dose lost an average of about 21 percent of body weight over roughly 72 weeks. These figures apply only to the investigational drug product, population, dosing, and conditions studied and do not apply to compounded formulations. Individual results vary and are never guaranteed.

What it's like to take

It's a once-weekly injection from a single-dose pen, or increasingly a vial you draw up yourself. You start low and step up about every four weeks, and those early increases are where most people feel it. Once you reach a maintenance dose the whole thing fades into the background: a few seconds a week and you've stopped thinking about it.

Side effects, honestly

The side effects are the same digestive cast as the rest of the class. Nausea comes first, then constipation, the occasional bout of diarrhea, and some reflux. They cluster around dose increases and ease for most people within a week or two of each step. A minority never get comfortable at the higher doses and settle lower, which is a perfectly reasonable place to land.

Who it's for, and who it isn't

This is intended for eligible patients who meet the labeled criteria for chronic weight management and plan for ongoing care. It is not intended for short-term cosmetic weight loss. People with type 2 diabetes should discuss the separately approved diabetes indication and available treatment options with their prescriber.

The cost reality

The published list price for the branded product (Zepbound®) is around $1,086 a month. Manufacturer self-pay programs and savings cards may be available to eligible patients, while insurance coverage for chronic weight management varies. Confirm current terms with the manufacturer, insurer, and dispensing pharmacy.

Regulatory scope

This review does not evaluate or promote compounded tirzepatide products. Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing.

The bottom line

If maximum results matter to you and a weekly injection isn't a dealbreaker, tirzepatide is the strongest option available today. Expect a rough first month, a manageable stretch after that, and an honest conversation with your prescriber about cost and how long you plan to stay on it.

How it compares

Patient reviews